• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.20% Nasdaq Down 0.13%

    Synergy Pharmaceuticals, Inc. (SGYP)

    -NasdaqGS
    4.40 Up 0.04(0.92%) 3:46PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:4.36
    Open:4.35
    Bid:4.41 x 3000
    Ask:4.42 x 1200
    1y Target Est:8.25
    Beta:1.87
    Next Earnings Date:N/A
    Day's Range:4.30 - 4.47
    52wk Range:2.45 - 4.68
    Volume:2,002,880
    Avg Vol (3m):2,121,400
    Market Cap:440.20M
    P/E (ttm):N/A
    EPS (ttm):-1.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    SGYPUp 0.92%440.20M
    IRWDUp 0.59%1.95B
    SLXP 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.05
    Quarterly EPS Est (Jun-15) :-0.27
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback